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A Practical Approach to Electrode-Skin Impedance
Unbalance Measurement
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Abstract—Unbalance between electrode-skin impedances is a major
problem in biopotential recordings, leading to increased power-line
interference. This paper proposes a simple, direct method to measure
that unbalance at power-line frequency (50–60 Hz), thus allowing the
determination of actual recording conditions for biopotential amplifiers.
The method is useful in research, amplifier testing, electrode design and
teaching purposes. It has been experimentally validated by using both
phantom impedances and real electrode-skin impedances.
Index Terms—Biopotential amplifier, electrode-skin impedance, power-
line interference.
I. INTRODUCTION
Power lines are a major source of electromagnetic interference
(EMI) in biopotential measurements. Power line interference affects
biopotential recording in many ways, as reported elsewhere [1]–[3].
Capacitive and inductive coupling between power lines and electrode
leads can be reduced by carefully shielding and twisting those leads,
but the displacement current iP coupled to the patient (see Fig. 1)
yields a common mode voltage, which is higher in two-electrode
systems than in systems using a third (ground) electrode. Because of
unbalances between electrode impedances and/or common mode input
impedances, that patient common mode voltage yields a differential
mode voltage at the amplifier input, which is consequently amplified.
That conversion from common to differential mode is also called “po-
tential divider effect” and yields an input-referenced differential-mode
interference voltage VD:EMI whose value is [1], [2]
VD:EMI = VCM
ZE
ZC
ZE
ZE
+
ZC
ZC
(1)
where VCM is the patient common mode voltage, ZC is the average
common-mode input impedance, ZC is the unbalance in that
impedance, ZE is the average electrode-skin impedance and ZE is
the electrode-skin unbalance
ZE =
ZE1 + ZE1
2
; ZE = ZE1   ZE1: (2)
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Fig. 1. System proposed to measure electrode-skin impedance unbalance.
Balanced common mode input impedances are not difficult to
achieve by a careful amplifier design, but electrode impedances
depend on skin preparation and site placement, so that their value is
very difficult to control. As a result, the dominant interference voltage
in (1) is
VD:EMI = VCM
ZE
ZC
(3)
which shows the importance of small electrode impedance unbalances
to reduce interference. For amplifier testing, if we first determine elec-
trode unbalance, the resulting interference will depend only on the
amplifier [4]. On the other hand, in electrode design, if we know the
common-mode input impedance of the amplifier, the interference will
be a result of electrode impedance unbalance.
In order to check whether measurement conditions are acceptable or
not (i.e. if the electrode-skin contact is good), many commercial sys-
tems measure individual electrode impedances (“electrode test” fea-
ture). However, that measurement is performed at frequencies other
than power line frequency (usually 10 Hz) and provides only quali-
tative information, which is not enough to verify good EMI measure-
ment conditions because, according to (3), the interference does not de-
pend on individual electrode impedances but on electrode unbalance at
power-line frequency. Electrode unbalance measurements are required,
for example, to test a new biopotential amplifier design under specific
unbalance conditions [4], in high-resolution recordings (to minimize
interference), and in electrode design (to test possible effects from dif-
ferent gel composition, for example). These measurements are also
very instructive for students in laboratory experiments.
Standard impedance measurements are performed by injecting a cur-
rent and sensing the potential difference across the electrode-skin inter-
face. This implies that two series electrode-skin impedances are mea-
sured. An alternative “three-lead” technique can be used instead [5],
which can measure single-electrode impedances. However, to avoid in-
teraction with power-line interference, these measurements are not per-
formed at power-line frequency. An ingenious measurement method
working at power line frequency uses the power line itself to generate
the current injected [6]. This method allows the measurement of single
electrode impedances at 50–60 Hz and can be adapted for electrode
unbalance measurements. However, determining electrode unbalance
would imply two single electrode impedance measurements (each with
real and imaginary parts) and then calculate their difference. This paper
0018-9294/$20.00 © 2006 IEEE
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improves the technique described in [6] to directly determine elec-
trode-skin impedance unbalance at power line frequency (50–60 Hz).
The method does not require an ad-hoc circuit and any biopotential
amplifier can be adapted to perform the measurement.
II. MEASUREMENT METHOD
The proposed method starts from (3) by solving for the modulus of
ZE
jZE j =
jVD:EMIjjZCj
jVCMj
: (4)
If ZC is known, measuring jVD:EMIj and jVCMj yields jZEj. The
phase of ZE could also be determined, indicating which electrode
has the higher electrode-skin impedance, but this is not usually of much
interest.
Fig. 1 shows a circuit to implement the proposed measurement
method. The external resistors RC ensure a well-known common
mode input impedance. Their value must be high enough for the
linear approximation implied in (1) to be acceptable, but small enough
to ensure the potential divider effect predominate over the direct
differential mode interference in Fig. 1 (power line voltage drop across
the tissue between E1 and E2). A value of RC of around 10 M
 is a
good compromise and limits patient fault currents to less than 50 A.
Two resistors RC = 9:1 M
 (1% tolerance) were used. Obviously,
if the amplifier has a known input resistance whose value is close to
10 M
, there is no need to add external resistors RC. To apply the
method to three-electrode amplifiers, the third (right-leg) electrode
must be disconnected. The differential mode voltage VD:EMI is the
input voltage of the instrumentation amplifier and the common mode
voltage VCM is obtained by splitting the gain-setting resistor RG used
in a three-op amp instrumentation amplifier and measuring the mid
voltage. The output low pass filters reduce noise bandwidth by attenu-
ating power line harmonics higher than 50 or 60 Hz. Input protections
(i.e. defibrillator protections, pacemaker pulse rejection circuits) do
not affect the electrode unbalance measurement. Electrode leads were
shielded and twisted to avoid interference effects not included in the
derivation of (3).
The circuit in Fig. 1 applies to nonisolated systems, which are
common in biopotential amplifier development, but can also be ap-
plied to isolated amplifiers, which are mandatory for measurements on
patients. However, these yield a lower VCM voltage (a few millivolts
compared to up to 1 V for nonisolated systems), because only a
fraction of the patient potential produces a common mode voltage [2];
most of the patient voltage drops across the impedance between the
isolated ground and earth ground. For isolated amplifiers, is necessary
to amplify VCM and the voltages in (4) must be measured by using
systems referred to the floating (signal) ground.
III. EXPERIMENTAL RESULTS
The proposed method has been validated by running several exper-
iments using known electrode impedance unbalances (phantom), and
real electrode impedances.
A. Measurement of Known Impedance Unbalances
This test was performed by placing one electrode on the patient
and adding a resistor, simulating an electrode impedance unbalance,
as shown in Fig. 2.
Differential (VD:EMI) and common mode (VCM) potentials were
measured using for ZE metal film resistors (1% tolerance) of 10 k

and 20 k
. To verify the relationship given by (3) for each ZE, dif-
ferent values for VCM were obtained by modifying the patient cou-
Fig. 2. Arrangement used to test the measurement method with known
impedance unbalances.
Fig. 3. Relationship between common mode and differential mode interference
voltage forZ = 10k
 andZ = 20k
. Experimental data are indicated
with markers and the theoretical curve in dashed line.
pling capacitance CP in Fig. 1. This was accomplished, for example,
by touching the subject, asking him to touch a large table, or by placing
him close to an insulated power line cord.
The experimental results are plotted in Fig. 3. Experimental data
points closely follow a straight line, as predicted by (3). The standard
deviation between samples was small, so that a single measurement
yields a good estimate of the electrode impedance unbalance.
B. Measurement of Electrode-Skin Unbalances
To measure actual skin-electrode impedances, two plate electrodes
(12 cm2 area) were placed on the right and left inner arms of the pa-
tient (ECG lead I). The results are in Fig. 4 (circles). In a second ex-
periment, the electrode impedance unbalance between a plate electrode
(right arm) and a cup electrode (left arm) were measured, which should
result in unbalances significantly larger than those obtained for two
similar electrodes placed on the same locations. The experimental data
are also shown in Fig. 4 (triangles). All the measurements were made
15 min after electrode application.
The results in Fig. 4 follow a straight line as predicted by (3). Non-
surprisingly, electrode unbalance is larger for dissimilar electrodes. The
standard deviation of the unbalance was about 1%. VD:EMI and VCM
were both measured by a digital oscilloscope (Tektronix TDS3012)
working in “averaging” mode triggered by “line,” which “blurred” the
ECG signal superimposed on VD:EMI. When CP is large enough (i.e.
when touching the subject), the interference signals can be measured
with a standard digital multimeter.
IV. CONCLUSION
A method for the direct measurement of electrode-skin unbalances
at 50–60 Hz has been presented. It relies on the model described by (3)
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Fig. 4. Experimental data for the impedance unbalance between two plate (12
cm ) electrodes (circles) and between a plate electrode and a cup electrode (tri-
angles).
an on a simple circuit that can be applied to most standard biopotential
amplifiers. The method was validated with known unbalances (resis-
tors) and also with real electrode-skin impedances. The results showed
a very low dispersion (standard deviation of around 1%). The method
is simple to implement and can be used in amplifier and electrode re-
search and also for teaching purposes.
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